{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T04:55:17Z","timestamp":1696308917542},"reference-count":86,"publisher":"Hindawi Limited","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":365,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1111\/ijcp.12447","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T07:05:24Z","timestamp":1409987124000},"page":"1165-1173","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Are we shortchanging frail older people when it comes to the pharmacological treatment of urgency urinary incontinence?"],"prefix":"10.1155","volume":"68","author":[{"given":"W.","family":"Gibson","sequence":"first","affiliation":[{"name":"Division of Geriatric Medicine; University of Alberta; Edmonton AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Athanasopoulos","sequence":"additional","affiliation":[{"name":"Department of Urology; Univesity of Patras; Patra Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Goldman","sequence":"additional","affiliation":[{"name":"Cleveland Clinic; Glickman Urologic and Kidney Institute; Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Madersbacher","sequence":"additional","affiliation":[{"name":"Department of Neurology; Innsbruck Medical University; Innsbruck Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Newman","sequence":"additional","affiliation":[{"name":"Division of Urology; Penn Center for Continence and Pelvic Health; University of Pennsylvania Medical Center; Philadelphia; PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Spinks","sequence":"additional","affiliation":[{"name":"Court View Surgery; Rochester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Wyndaele","sequence":"additional","affiliation":[{"name":"Urology and Urological Rehabilitation; University Hospital Antwerp; Antwerp Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wagg","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Alberta; Edmonton AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,9,6]]},"reference":[{"issue":"2","key":"10.1111\/ijcp.12447-BIB0001|ijcp12447-cit-0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1111\/ijcp.12447-BIB0002|ijcp12447-cit-0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/ijcp.12447-BIB0003|ijcp12447-cit-0003","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/01.ju.0000142429.59753.5c","article-title":"Detrusor overactivity. Does it represent a difference if patients feel the involuntary contractions?","volume":"1","author":"Wyndaele","year":"2004","journal-title":"J Urol"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0004|ijcp12447-cit-0004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1464-410X.2003.04351.x","article-title":"Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response","volume":"92","author":"Malone-Lee","year":"2003","journal-title":"BJU Int"},{"issue":"7","key":"10.1111\/ijcp.12447-BIB0005|ijcp12447-cit-0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF03262272","article-title":"Antimuscarinic treatment in overactive bladder: special considerations in elderly patients","volume":"29","author":"Wagg","year":"2012","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0006|ijcp12447-cit-0006","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"issue":"11","key":"10.1111\/ijcp.12447-BIB0007|ijcp12447-cit-0007","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0895-4356(00)00232-8","article-title":"A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag","volume":"53","author":"Hannestad","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1111\/ijcp.12447-BIB0008|ijcp12447-cit-0008","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1464-410X.1990.tb14992.x","article-title":"Oxybutynin hydrochloride (3\u00a0mg) in the treatment of women with idiopathic detrusor instability","volume":"66","author":"Moore","year":"1990","journal-title":"Br J Urol"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0009|ijcp12447-cit-0009","first-page":"CD003781","article-title":"Anticholinergic drugs versus placebo for overactive bladder syndrome in adults","volume":"4","author":"Nabi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1111\/ijcp.12447-BIB0010|ijcp12447-cit-0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0090-4295(76)90273-9","article-title":"Oxybutynin in bladder spasm, neurogenic bladder, and enuresis","volume":"8","author":"Thompson","year":"1976","journal-title":"Urology"},{"issue":"3","key":"10.1111\/ijcp.12447-BIB0011|ijcp12447-cit-0011","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08998280.2007.11928310","article-title":"Agents for treatment of overactive bladder: a therapeutic class review","volume":"20","author":"Hesch","year":"2007","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1111\/ijcp.12447-BIB0012|ijcp12447-cit-0012","first-page":"CD005429","article-title":"Which anticholinergic drug for overactive bladder symptoms in adults","volume":"1","author":"Madhuvrata","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0013|ijcp12447-cit-0013","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1464-410X.1988.tb04356.x","article-title":"Oxybutynin: is it safe?","volume":"62","author":"Baigrie","year":"1988","journal-title":"Br J Urol"},{"issue":"1-2","key":"10.1111\/ijcp.12447-BIB0014|ijcp12447-cit-0014","first-page":"37","article-title":"Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment","volume":"11","author":"Riva","year":"1984","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0015|ijcp12447-cit-0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5347(17)38459-8","article-title":"Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo","volume":"145","author":"Thuroff","year":"1991","journal-title":"J Urol"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0016|ijcp12447-cit-0016","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-0528.1990.tb02523.x","article-title":"The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study","volume":"97","author":"Tapp","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0017|ijcp12447-cit-0017","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.bpg.2009.09.001","article-title":"Constipation in old age","volume":"23","author":"Gallagher","year":"2009","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"11","key":"10.1111\/ijcp.12447-BIB0018|ijcp12447-cit-0018","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1464-410X.2012.11023.x","article-title":"Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience","volume":"110","author":"Wagg","year":"2012","journal-title":"BJU Int"},{"issue":"3","key":"10.1111\/ijcp.12447-BIB0019|ijcp12447-cit-0019","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02550401","article-title":"Oxybutynin hydrochloride in the management of detrusor instability","volume":"22","author":"Primus","year":"1990","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"10.1111\/ijcp.12447-BIB0020|ijcp12447-cit-0020","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/j.1532-5415.2005.00537.x","article-title":"Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients","volume":"53","author":"Kay","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1111\/ijcp.12447-BIB0021|ijcp12447-cit-0021","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clinthera.2005.02.014","article-title":"Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly","volume":"27","author":"Scheife","year":"2005","journal-title":"Clin Ther"},{"issue":"1-2","key":"10.1111\/ijcp.12447-BIB0022|ijcp12447-cit-0022","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2009.02.321","article-title":"Blood-brain barrier alterations in ageing and dementia","volume":"283","author":"Popescu","year":"2009","journal-title":"J Neurol Sci"},{"issue":"5-6","key":"10.1111\/ijcp.12447-BIB0023|ijcp12447-cit-0023","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lfs.2010.06.008","article-title":"Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography","volume":"87","author":"Yoshida","year":"2010","journal-title":"Life Sci"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0024|ijcp12447-cit-0024","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00191165","article-title":"Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers","volume":"47","author":"Pietzko","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1111\/ijcp.12447-BIB0025|ijcp12447-cit-0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2011.06.031","article-title":"Effect of oxybutynin and imidafenacin on central muscarinic receptor occupancy and cognitive function: a monkey PET study with [(11)C](+)3-MPB","volume":"58","author":"Yamamoto","year":"2011","journal-title":"Neuroimage"},{"issue":"1","key":"10.1111\/ijcp.12447-BIB0026|ijcp12447-cit-0026","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1532-5415.1998.tb01006.x","article-title":"Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride","volume":"46","author":"Katz","year":"1998","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"10.1111\/ijcp.12447-BIB0027|ijcp12447-cit-0027","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1742-1241.2010.02433.x","article-title":"Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder","volume":"64","author":"Staskin","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1111\/ijcp.12447-BIB0028|ijcp12447-cit-0028","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2013.01.002","article-title":"Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study","volume":"64","author":"Wagg","year":"2013","journal-title":"Eur Urol"},{"issue":"3","key":"10.1111\/ijcp.12447-BIB0029|ijcp12447-cit-0029","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2012.05.2543","article-title":"Evaluation of cognitive function in healthy older subjects treated with fesoterodine","volume":"124","author":"Kay","year":"2012","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1111\/ijcp.12447-BIB0030|ijcp12447-cit-0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.eururo.2006.03.057","article-title":"Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects","volume":"50","author":"Kay","year":"2006","journal-title":"Eur Urol"},{"issue":"11","key":"10.1111\/ijcp.12447-BIB0031|ijcp12447-cit-0031","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1742-1241.2008.01849.x","article-title":"Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin","volume":"62","author":"Kay","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.1111\/ijcp.12447-BIB0032|ijcp12447-cit-0032","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1532-5415.2008.01681.x","article-title":"Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes","volume":"56","author":"Sink","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"10.1111\/ijcp.12447-BIB0033|ijcp12447-cit-0033","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1532-5415.2011.03473.x","article-title":"Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events?","volume":"59","author":"Paquette","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0034|ijcp12447-cit-0034","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1464-410X.2006.06658.x","article-title":"Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study","volume":"99","author":"Sand","year":"2007","journal-title":"BJU Int"},{"key":"10.1111\/ijcp.12447-BIB0035|ijcp12447-cit-0035","article-title":"Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and\/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study","author":"Goldfischer","year":"2013","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0036|ijcp12447-cit-0036","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00192-012-1915-8","article-title":"Oxybutynin: past, present, and future","volume":"24","author":"Jirschele","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0037|ijcp12447-cit-0037","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.eururo.2006.11.033","article-title":"Transdermal oxybutynin: sticking to the facts","volume":"51","author":"Cartwright","year":"2007","journal-title":"Eur Urol"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0038|ijcp12447-cit-0038","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1185\/030079902125000570","article-title":"Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: the antimuscarinic clinical effectiveness trial (ACET)","volume":"18","author":"Sussman","year":"2002","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1111\/ijcp.12447-BIB0039|ijcp12447-cit-0039","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0029-7844(99)00661-4","article-title":"Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group","volume":"95","author":"Versi","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0040|ijcp12447-cit-0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00345-005-0507-3","article-title":"Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder","volume":"23","author":"Zinner","year":"2005","journal-title":"World J Urol"},{"issue":"8","key":"10.1111\/ijcp.12447-BIB0041|ijcp12447-cit-0041","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1517\/14656566.6.8.1409","article-title":"Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder","volume":"6","author":"Zinner","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0042|ijcp12447-cit-0042","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ageing\/afr115","article-title":"Improving recruitment of older people to research through good practice","volume":"40","author":"McMurdo","year":"2011","journal-title":"Age Ageing"},{"issue":"5","key":"10.1111\/ijcp.12447-BIB0043|ijcp12447-cit-0043","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"issue":"3","key":"10.1111\/ijcp.12447-BIB0044|ijcp12447-cit-0044","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0045|ijcp12447-cit-0045","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.eururo.2010.06.007","article-title":"Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review","volume":"58","author":"Irwin","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1111\/ijcp.12447-BIB0046|ijcp12447-cit-0046","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10620-010-1313-3","article-title":"Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials","volume":"56","author":"Meek","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0047|ijcp12447-cit-0047","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.eururo.2012.08.060","article-title":"Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses","volume":"62","author":"Buser","year":"2012","journal-title":"Eur Urol"},{"issue":"2","key":"10.1111\/ijcp.12447-BIB0048|ijcp12447-cit-0048","doi-asserted-by":"crossref","first-page":"e16718","DOI":"10.1371\/journal.pone.0016718","article-title":"Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach","volume":"6","author":"Kessler","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0049|ijcp12447-cit-0049","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"60","author":"American Geriatrics Society Beers Criteria Update Expert Panel","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0050|ijcp12447-cit-0050","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ageing\/afn197","article-title":"STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria","volume":"37","author":"Gallagher","year":"2008","journal-title":"Age Ageing"},{"issue":"31-32","key":"10.1111\/ijcp.12447-BIB0051|ijcp12447-cit-0051","first-page":"543","article-title":"Potentially inappropriate medications in the elderly: the PRISCUS list","volume":"107","author":"Holt","year":"2010","journal-title":"Dtsch Arztebl Int"},{"key":"10.1111\/ijcp.12447-BIB0052|ijcp12447-cit-0052","unstructured":"CG171 urinary incontinence in women 2013 http:\/\/guidance.nice.org.uk\/CG171\/NICEGuidance\/pdf\/English"},{"key":"10.1111\/ijcp.12447-BIB0053|ijcp12447-cit-0053","unstructured":"McDonagh MS Selover D Santa J Thakurta S Drug class review: agents for overactive bladder Portland, OR 2009"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0054|ijcp12447-cit-0054","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0025-6196(11)62382-3","article-title":"Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study","volume":"76","author":"Appell","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1111\/ijcp.12447-BIB0055|ijcp12447-cit-0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1464-410X.2003.04468.x","article-title":"Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial","volume":"92","author":"Homma","year":"2003","journal-title":"BJU Int"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0056|ijcp12447-cit-0056","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"Br J Urol"},{"issue":"5","key":"10.1111\/ijcp.12447-BIB0057|ijcp12447-cit-0057","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1442-2042.2002.00460.x","article-title":"Tolterodine: as effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder","volume":"9","author":"Lee","year":"2002","journal-title":"Int J Urol"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0058|ijcp12447-cit-0058","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00345-003-0321-8","article-title":"Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability","volume":"20","author":"Halaska","year":"2003","journal-title":"World J Urol"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0059|ijcp12447-cit-0059","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4065\/78.6.687","article-title":"Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial","volume":"78","author":"Diokno","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0060|ijcp12447-cit-0060","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1464-410X.1995.tb07264.x","article-title":"Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia","volume":"75","author":"Madersbacher","year":"1995","journal-title":"Br J Urol"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0061|ijcp12447-cit-0061","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1159\/000020222","article-title":"Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects","volume":"37","author":"Bemelmans","year":"2000","journal-title":"Eur Urol"},{"key":"10.1111\/ijcp.12447-BIB0062|ijcp12447-cit-0062","first-page":"2","article-title":"A randomised cross over trial comparing oxybutynin taken three times a day or taken \u2018when needed\u2019","volume":"13","author":"Burton","year":"1994","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0063|ijcp12447-cit-0063","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ageing\/24.4.287","article-title":"Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial","volume":"24","author":"Szonyi","year":"1995","journal-title":"Age Ageing"},{"issue":"4 Suppl","key":"10.1111\/ijcp.12447-BIB0064|ijcp12447-cit-0064","first-page":"S130","article-title":"Medical costs after initiation of drug treatment for overactive bladder: effects of selection bias on cost estimates","volume":"11","author":"Nitz","year":"2005","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1111\/ijcp.12447-BIB0065|ijcp12447-cit-0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3111\/13696998.2010.509244","article-title":"Canadian cost-effectiveness analysis of solifenacin compared to oxybutynin immediate-release in patients with overactive bladder","volume":"13","author":"Herschorn","year":"2010","journal-title":"J Med Econ"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0066|ijcp12447-cit-0066","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2165\/00044011-200424060-00001","article-title":"Cost effectiveness of controlled-release oxybutynin compared with immediate-release oxybutynin and tolterodine in the treatment of overactive bladder in the UK, France and Austria","volume":"24","author":"Guest","year":"2004","journal-title":"Clin Drug Investig"},{"issue":"2","key":"10.1111\/ijcp.12447-BIB0067|ijcp12447-cit-0067","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-410X.2011.10729.x","article-title":"Cost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry","volume":"110","author":"Nilsson","year":"2012","journal-title":"BJU Int"},{"issue":"1","key":"10.1111\/ijcp.12447-BIB0068|ijcp12447-cit-0068","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2005.02.024","article-title":"The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis","volume":"48","author":"Chapple","year":"2005","journal-title":"Eur Urol"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0069|ijcp12447-cit-0069","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1464-410X.2009.09160.x","article-title":"The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service","volume":"106","author":"Cardozo","year":"2010","journal-title":"BJU Int"},{"issue":"4 Suppl","key":"10.1111\/ijcp.12447-BIB0070|ijcp12447-cit-0070","first-page":"S140","article-title":"Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially insured persons with overactive bladder","volume":"11","author":"Varadharajan","year":"2005","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1111\/ijcp.12447-BIB0071|ijcp12447-cit-0071","first-page":"117","article-title":"The effects of a continence program on frail community-dwelling elderly persons","volume":"23","author":"Colling","year":"2003","journal-title":"Urol Nurs"},{"issue":"4","key":"10.1111\/ijcp.12447-BIB0072|ijcp12447-cit-0072","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.AOG.0000206213.48334.09","article-title":"The \u201ccosts\u201d of urinary incontinence for women","volume":"107","author":"Subak","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"4 Suppl","key":"10.1111\/ijcp.12447-BIB0073|ijcp12447-cit-0073","first-page":"S121","article-title":"Persistence with overactive bladder pharmacotherapy in a Medicaid population","volume":"11","author":"Shaya","year":"2005","journal-title":"Am J Manag Care"},{"issue":"1","key":"10.1111\/ijcp.12447-BIB0074|ijcp12447-cit-0074","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11884-010-0080-5","article-title":"Pharmacodynamics of overactive bladder drugs: shifting the curve","volume":"6","author":"Staskin","year":"2011","journal-title":"Curr Bladder Dysfunct Rep"},{"issue":"2","key":"10.1111\/ijcp.12447-BIB0075|ijcp12447-cit-0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.2011.03961.x","article-title":"A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder","volume":"72","author":"Callegari","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1111\/ijcp.12447-BIB0076|ijcp12447-cit-0076","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF03261924","article-title":"Cognitive effects of oxybutynin chloride topical gel in older healthy subjects: a 1-week, randomized, double-blind, placebo- and active-controlled study","volume":"32","author":"Kay","year":"2012","journal-title":"Clin Drug Investig"},{"issue":"8","key":"10.1111\/ijcp.12447-BIB0077|ijcp12447-cit-0077","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1185\/03007995.2012.709837","article-title":"An evaluation of patient and physician satisfaction with controlled-release oxybutynin 15\u00a0mg as a one-step daily dose in elderly and non-elderly patients with overactive bladder: results of the STOP study","volume":"28","author":"Aaron","year":"2012","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1111\/ijcp.12447-BIB0078|ijcp12447-cit-0078","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1742-1241.2011.02838.x","article-title":"Prescription pattern of oxybutynin ER in patients with overactive bladder in real life practice: a multicentre, open-label, prospective observational study","volume":"66","author":"Yoo","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.1111\/ijcp.12447-BIB0079|ijcp12447-cit-0079","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1532-5415.2008.01680.x","article-title":"Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence","volume":"56","author":"Lackner","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"10.1111\/ijcp.12447-BIB0080|ijcp12447-cit-0080","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jamda.2010.05.003","article-title":"Efficacy of oral extended-release oxybutynin in cognitively impaired older nursing home residents with urge urinary incontinence: a randomized placebo-controlled trial","volume":"12","author":"Lackner","year":"2011","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"10.1111\/ijcp.12447-BIB0081|ijcp12447-cit-0081","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1185\/03007995.2010.541433","article-title":"Tolerability of solifenacin and oxybutynin immediate release in older (> 65\u00a0years) and younger (<\/= 65\u00a0years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study","volume":"27","author":"Herschorn","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"10.1111\/ijcp.12447-BIB0082|ijcp12447-cit-0082","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1701-2163(16)32604-4","article-title":"Randomized trial of oxybutynin extended versus immediate release for women aged 65 and older with overactive bladder: lessons learned from conducting a trial","volume":"29","author":"Minassian","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"issue":"5","key":"10.1111\/ijcp.12447-BIB0083|ijcp12447-cit-0083","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1532-5415.2005.53260.x","article-title":"Effects of behavioral and drug therapy on nocturia in older incontinent women","volume":"53","author":"Johnson","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.1111\/ijcp.12447-BIB0084|ijcp12447-cit-0084","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1532-5415.2002.50204.x","article-title":"Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women","volume":"50","author":"Goode","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1111\/ijcp.12447-BIB0085|ijcp12447-cit-0085","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1532-5415.1995.tb07193.x","article-title":"Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial","volume":"43","author":"Ouslander","year":"1995","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1111\/ijcp.12447-BIB0086|ijcp12447-cit-0086","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/ageing\/18.3.195","article-title":"Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study","volume":"18","author":"Zorzitto","year":"1989","journal-title":"Age Ageing"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12447","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:08:48Z","timestamp":1643350128000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12447","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"2014-09-06","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}